$ARVN 4 SEC Filings

Filed On	Filing
26 Jun 2026	Form 4: Smaldone Alsup Laurie, Director Received 15,527 shares as a grant or award · Granted 22,714 Stock Option (right to buy)
26 Jun 2026	Form 4: Norwalk Leslie V, Director Received 15,527 shares as a grant or award · Granted 22,714 Stock Option (right to buy)
26 Jun 2026	Form 4: Morrison Briggs, Director Received 15,527 shares as a grant or award · Granted 22,714 Stock Option (right to buy)
26 Jun 2026	Form 4: Kennedy Edward Moore Jr., Director Received 15,527 shares as a grant or award · Granted 22,714 Stock Option (right to buy)
26 Jun 2026	Form 4: Cunningham Everett, Director Received 15,527 shares as a grant or award · Granted 22,714 Stock Option (right to buy)
26 Jun 2026	Form 4: Bain Linda, Director Received 15,527 shares as a grant or award · Granted 22,714 Stock Option (right to buy)
24 Jun 2026	Form 4: Saik Andrew, Chief Financial Officer Sold 5,696 shares ($46.5K)
18 Jun 2026	Form 4: Cacace Angela M, Chief Scientific Officer Sold 2,576 shares ($19.6K)
22 May 2026	Form 4: Teel Randy, Director Sold 2,209 shares ($20K)
13 May 2026	Form 4: Saik Andrew, Chief Financial Officer Sold 11,139 shares ($111K)
13 May 2026	Form 4: Loomis David K, VP, Chief Accounting Officer Sold 1,919 shares ($19.1K)
13 May 2026	Form 4: Cacace Angela M, Chief Scientific Officer Sold 9,657 shares ($96K)
13 May 2026	Form 4: Berkowitz Noah, Chief Medical Officer Sold 11,108 shares ($110K)
13 May 2026	Form 4: Teel Randy, Director Sold 9,657 shares ($96K)
19 Mar 2026	Form 4: Berkowitz Noah, Chief Medical Officer Sold 6,435 shares ($71.4K)
09 Mar 2026	Form 4: Morrison Briggs, Director Bought 20,000 shares ($268K)
02 Mar 2026	Form 4: Loomis David K, VP, Chief Accounting Officer Received 12,420 shares as a grant or award · Granted 18,504 Stock Option (right to buy)
02 Mar 2026	Form 4: Cacace Angela M, Chief Scientific Officer Received 45,000 shares as a grant or award · Granted 67,000 Stock Option (right to buy)
02 Mar 2026	Form 4: Berkowitz Noah, Chief Medical Officer Received 45,000 shares as a grant or award · Granted 67,000 Stock Option (right to buy)
02 Mar 2026	Form 4: Saik Andrew, Chief Financial Officer Received 45,000 shares as a grant or award · Granted 67,000 Stock Option (right to buy)

Comments